Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,194.65 +3,813.93 (+6.42%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
The Carlyle Group Inc. (CG)
After hours:
- Zacks
After Plunging -13.6% in 4 Weeks, Here's Why the Trend Might Reverse for Carlyle (CG)
Carlyle (CG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- GlobeNewswire
Acentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access Commission
Verlon Johnson Acentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access Commission MCLEAN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, announced today that Acentra Health Executive Vice President and Chief Strategy Officer Verlon Johnson, MPA, has been appoint
- Insider Monkey
The Carlyle Group Inc. (NASDAQ:CG) Q1 2024 Earnings Call Transcript
The Carlyle Group Inc. (NASDAQ:CG) Q1 2024 Earnings Call Transcript May 1, 2024 The Carlyle Group Inc. beats earnings expectations. Reported EPS is $1.01, expectations were $0.92. The Carlyle Group Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good […]
